Refractory multiple myeloma means that your blood cancer isn’t responding to treatment. Your doctor may also refer to this as “progressive disease.” Hearing that your treatment isn’t slowing the ...
In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after ...
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes Phase II eligible patients had RRMM that either ...
The management of chronic cough is described in evidence-based guidelines that appear to be effective for diagnosing and treating the many underlying causes of chronic cough. However, the management ...
The majority of patients with locally advanced or metastatic prostate cancer treated by continuous androgen deprivation using either maximum androgen blockade (MAB) or GnRH analogue with deferred ...
Refractory chronic migraine is diagnosed when typical migraine treatments fail to reduce the frequency of episodes, leading to a significant number of headache days per month. The condition can be ...
Refractory multiple myeloma is defined as myeloma cancer that either does not respond to initial treatment or stops responding to it. Common symptoms of refractory multiple myeloma can be remembered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results